PACS GROUP INC (PACS) Stock Fundamental Analysis
USA - NYSE:PACS - US69380Q1076 - Common Stock
10.7 USD
-0.76 (-6.63%)
10.7 USD
0 (0%)
Taking everything into account, PACS scores 3 out of 10 in our fundamental rating. PACS was compared to 100 industry peers in the Health Care Providers & Services industry. PACS may be in some trouble as it scores bad on both profitability and health. PACS has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
PACS had positive earnings in the past year.
1.2 Ratios
PACS has a better Return On Assets (2.90%) than 63.00% of its industry peers.
PACS's Return On Equity of 19.73% is amongst the best of the industry. PACS outperforms 87.00% of its industry peers.
PACS's Return On Invested Capital of 4.38% is in line compared to the rest of the industry. PACS outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.9% | ||
| ROE | 19.73% | ||
| ROIC | 4.38% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 3.63%, PACS is doing good in the industry, outperforming 71.00% of the companies in the same industry.
Looking at the Operating Margin, with a value of 6.68%, PACS is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
The Gross Margin of PACS (21.33%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.68% | ||
| PM (TTM) | 3.63% | ||
| GM | 21.33% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
PACS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PACS remains at a similar level compared to 1 year ago.
Compared to 1 year ago, PACS has a worse debt to assets ratio.
2.2 Solvency
PACS has an Altman-Z score of 1.43. This is a bad value and indicates that PACS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of PACS (1.43) is worse than 66.00% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that PACS is somewhat dependend on debt financing.
PACS has a Debt to Equity ratio of 0.90. This is comparable to the rest of the industry: PACS outperforms 42.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.43 |
ROIC/WACC0.48
WACC9.12%
2.3 Liquidity
PACS has a Current Ratio of 1.71. This is a normal value and indicates that PACS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.71, PACS is in the better half of the industry, outperforming 63.00% of the companies in the same industry.
A Quick Ratio of 1.71 indicates that PACS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.71, PACS is doing good in the industry, outperforming 68.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.71 |
3. Growth
3.1 Past
The earnings per share for PACS have decreased strongly by -25.00% in the last year.
Looking at the last year, PACS shows a very strong growth in Revenue. The Revenue has grown by 28.47%.
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.3%
Revenue 1Y (TTM)28.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%29.08%
3.2 Future
Based on estimates for the next years, PACS will show a very strong growth in Earnings Per Share. The EPS will grow by 37.45% on average per year.
The Revenue is expected to grow by 18.92% on average over the next years. This is quite good.
EPS Next Y92.3%
EPS Next 2Y46.69%
EPS Next 3Y37.45%
EPS Next 5YN/A
Revenue Next Year28.62%
Revenue Next 2Y22.64%
Revenue Next 3Y18.92%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
PACS is valuated correctly with a Price/Earnings ratio of 14.08.
82.00% of the companies in the same industry are more expensive than PACS, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.91, PACS is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 6.51, the valuation of PACS can be described as very cheap.
Based on the Price/Forward Earnings ratio, PACS is valued cheaper than 96.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.57, PACS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.08 | ||
| Fwd PE | 6.51 |
4.2 Price Multiples
PACS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PACS is cheaper than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.58 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PACS's earnings are expected to grow with 37.45% in the coming years.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y46.69%
EPS Next 3Y37.45%
5. Dividend
5.1 Amount
PACS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.7
-0.76 (-6.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners29.06%
Inst Owner Change-2.65%
Ins Owners71.8%
Ins Owner Change0%
Market Cap1.66B
Revenue(TTM)3.11B
Net Income(TTM)112.87M
Analysts83.64
Price Target27.88 (160.56%)
Short Float %7.62%
Short Ratio3.23
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.28%
Min EPS beat(2)24.18%
Max EPS beat(2)56.37%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.83%
Min Revenue beat(2)2.62%
Max Revenue beat(2)5.03%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.17%
PT rev (3m)-20.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.08 | ||
| Fwd PE | 6.51 | ||
| P/S | 0.53 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.9 | ||
| P/tB | 3.28 | ||
| EV/EBITDA | 9.58 |
EPS(TTM)0.76
EY7.1%
EPS(NY)1.64
Fwd EY15.36%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS20.05
BVpS3.69
TBVpS3.27
PEG (NY)0.15
PEG (5Y)N/A
Graham Number7.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.9% | ||
| ROE | 19.73% | ||
| ROCE | 6.06% | ||
| ROIC | 4.38% | ||
| ROICexc | 4.47% | ||
| ROICexgc | 4.56% | ||
| OM | 6.68% | ||
| PM (TTM) | 3.63% | ||
| GM | 21.33% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.9 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.21 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.71 | ||
| Altman-Z | 1.43 |
F-ScoreN/A
WACC9.12%
ROIC/WACC0.48
Cap/Depr(3y)671.95%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.35%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.3%
EPS Next Y92.3%
EPS Next 2Y46.69%
EPS Next 3Y37.45%
EPS Next 5YN/A
Revenue 1Y (TTM)28.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%29.08%
Revenue Next Year28.62%
Revenue Next 2Y22.64%
Revenue Next 3Y18.92%
Revenue Next 5YN/A
EBIT growth 1Y-9.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.13%
EBIT Next 3Y32.1%
EBIT Next 5YN/A
FCF growth 1Y-74.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.22%
OCF growth 3YN/A
OCF growth 5YN/A
PACS GROUP INC / PACS FAQ
What is the fundamental rating for PACS stock?
ChartMill assigns a fundamental rating of 3 / 10 to PACS.
What is the valuation status for PACS stock?
ChartMill assigns a valuation rating of 6 / 10 to PACS GROUP INC (PACS). This can be considered as Fairly Valued.
What is the profitability of PACS stock?
PACS GROUP INC (PACS) has a profitability rating of 3 / 10.
What are the PE and PB ratios of PACS GROUP INC (PACS) stock?
The Price/Earnings (PE) ratio for PACS GROUP INC (PACS) is 14.08 and the Price/Book (PB) ratio is 2.9.
How financially healthy is PACS GROUP INC?
The financial health rating of PACS GROUP INC (PACS) is 3 / 10.